Shares of Cadila Healthcare have slipped 5% to Rs 336 per share, extending their 6% decline on Monday on the BSE, after the company reported a lower-than-expected 30% year on year (YoY) growth in net sales at Rs 28.94 billion in the June quarter (Q1FY19) due to lower US sales.
The company’s net profit grew by 233% YoY to Rs 4.60 billion in Q1FY19 due to other income of Rs 1.01 billion.
Analysts on an average had expected net sales of Rs 31.21 billion and profit of Rs 4.65 billion for the quarter.
The company’s business in the
The company’s net profit grew by 233% YoY to Rs 4.60 billion in Q1FY19 due to other income of Rs 1.01 billion.
Analysts on an average had expected net sales of Rs 31.21 billion and profit of Rs 4.65 billion for the quarter.
The company’s business in the